Clifford Starke - 15 Dec 2023 Form 4 Insider Report for Flora Growth Corp. (FLGC)

Signature
/s/ Dany Vaiman as attorney-in-fact for Clifford Starke
Issuer symbol
FLGC
Transactions as of
15 Dec 2023
Net transactions value
+$48.45
Form type
4
Filing time
06 Sep 2024, 17:25:10 UTC
Previous filing
15 Nov 2023
Next filing
09 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGC Common Shares Purchase $48.45 +51 +0.01% $0.9500 474,046 05 Sep 2024 Direct
holding FLGC Common Shares 565,714 15 Dec 2023 See footnote F1
holding FLGC Common Shares 300,347 15 Dec 2023 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLGC Stock Appreciation Rights ("SARs") Award $0 +1,028,665 $0.000000 1,028,665 15 Dec 2023 Common Shares 1,028,665 $1.21 Direct F3
transaction FLGC Stock Appreciation Rights ("SARs") Award $0 +575,319 $0.000000 575,319 14 Aug 2024 Common Shares 575,319 $0.9150 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by YT Research, Inc., a company in which the Reporting Person is the sole director and equity owner. The Reporting Person disclaims beneficial ownership of the securities held by YT Research, Inc. except to the extent of his pecuniary interest therein.
F2 Held by Hampstead Private Capital Limited, a company in which the Reporting Person is the sole director and equity owner. The Reporting Person disclaims beneficial ownership of the securities held by Hampstead Private Capital Limited except to the extent of his pecuniary interest therein.
F3 The SARs vest in 12 equal installments, subject to stock price criteria to be met prior to each tranche vesting. The SARs have a post-termination exercise period of one year.